Comments
- No comments found
- Urine volume and change in estimated GFR
- Home
-
About ISN
- Membership
- News
- Topics
- Programs
- Regions
- Initiatives
- Publications
-
Education
-
Education Topics
- Pathology Topics
- Acute Kidney Injury
- Anemia, Iron and trace elements
- Chronic Kidney Disease
- Diabetes
- Fluid and Electrolytes
- General Nephrology
- Global Nephrology
- Glomerular Disease
- Hemodialysis
- Hypertension
- Infections
- Interventional Nephrology
- Mineral and bone disorders
- Nutrition and Hydration
- Peritoneal Dialysis
- Systemic Disease
- Transplantation
- Research Methodology
- Urolithiasis
- Basic Science
-
Education Topics
- Events
Sunday, 13 April 2014 15:45
Approach to Partnership - Academia, Pharma and Governmental Organisations in developed and developing countries: Message from Africa audioicon
By Charles SwanepoelThis presentation was given by Charles Swanepoel from the Division of Nephrology at University of Cape Town. It was given during the ISN Nexus Symposium 2014 held in Bergamo, Italy on April 3-6, 2014. The focus this year was on the New era of drug discovery and clinical trials in kidney disease.
Additional Info
- Language: English
- Contains Audio: Yes
- Content Type: Presentations
- Source: ISN
- Event: Nexus
- Year: 2014
- Members Only: No
Read 1188 times
Last modified on Thursday, 17 April 2014 22:22
Published in
Global Nephrology
Tagged under
Download attachments:
- Download this presentation (520 Downloads)
Related items
- Drug discovery in kidney disease: from serendipity to rationality
- Fellow: Kamonwan Tangvoraphonkchai From Thailand
- RESULTS OF ARTS-DN: A RANDOMIZED STUDY TO ASSESS THE SAFETY AND EFFICACY OF FINERENONE IN PATIENTS WITH TYPE 2 DIABETES AND DIABETIC NEPHROPATHY
- Patients, Research and Drugs audioicon
- Interaction between academia, industry and government audioicon
|
Global Operations Center Rue des Fabriques 1 |
Americas Operations Center 340 North Avenue 3rd Floor |
Administrator Login
Leave your comments
Post comment as a guest